Migraine Treatment with Botox: Insurance Coverage and Reality

A patient walked into the Warner Robins clinic two months ago with a question that surfaces in my office every few weeks: she had heard that Botox could prevent her migraines, her cosmetic Botox provider had implied she could just "get more units" at her next appointment to handle them, and she wanted to know what was real. She had eighteen migraine days a month, two emergency department visits in the past year, and a regimen of triptans and over-the-counter NSAIDs that had stopped doing much of anything. She had been told by a primary care provider that she did not "really have chronic migraine, just frequent headaches."

She did really have chronic migraine. And the Botox protocol that prevents migraines is a completely different intervention than the cosmetic Botox she had been getting between her brows every six months. The conflation of these two things is one of the more frustrating misunderstandings I deal with in this practice, because the treatment that actually works for chronic migraine is FDA-approved, well-studied, often insurance-covered when properly documented, and almost never administered correctly outside of a neurology referral. This article is the structured version of the conversation I have with patients who arrive asking about it.

What chronic migraine actually is — the diagnostic threshold matters

The FDA approval for onabotulinumtoxinA (Botox) for migraine prevention is specifically for chronic migraine, defined as a headache on fifteen or more days per month for at least three months, with at least eight of those days meeting full migraine criteria. That definition matters because the indication, the protocol, and the insurance coverage all hinge on it.

Episodic migraine — fewer than fifteen headache days per month — is not an FDA-approved indication for Botox. The clinical evidence does not support the same protocol in episodic migraineurs. Some patients in the high end of the episodic range (10-14 days/month) do benefit, but the formal indication and insurance coverage stop at the chronic threshold.

When I evaluate a patient for migraine Botox candidacy, the first thing I am sorting out is which category they fall into. Headache diaries are the gold standard. I ask patients to track for at least four weeks before the candidacy conversation if they have not been tracking already. The diary should capture date, duration, severity, associated features (nausea, photophobia, phonophobia, aura), abortive medications used, and trigger context. There are several free apps that handle this well. The diary is not optional — it is the data that drives the clinical decision and the insurance authorization.

The PREEMPT protocol — what migraine Botox actually involves

The protocol is called PREEMPT, named after the trials that established it. It is specific, it is reproducible, and it is fundamentally different from cosmetic injection.

Dosing. A total of 155 to 195 units of onabotulinumtoxinA, distributed across 31 to 39 fixed and "follow-the-pain" injection sites. For comparison, a typical cosmetic glabellar treatment is 20-25 units total. The migraine protocol uses approximately seven times that.

Anatomical sites. Seven head and neck muscle groups: corrugator, procerus, frontalis, temporalis, occipitalis, cervical paraspinal, and trapezius. Specific dose per site, distribution pattern, and depth are protocol-defined.

Frequency. Treatments every twelve weeks on a fixed schedule. Skipping or delaying treatments reduces effectiveness.

Expected response. Onset of effect is typically by the second treatment cycle, with full effect emerging by the third. Patients should not judge whether the protocol is working after a single treatment. Approximately 50% of properly selected patients achieve a 50% or greater reduction in headache days at six months.

Mechanism. Botulinum toxin reduces release of acetylcholine, but it also reduces release of pain-related neuropeptides — CGRP, substance P, and glutamate — at peripheral trigeminal sensory terminals. The effect is local sensory nerve modulation, which is why the cosmetic dose at the cosmetic sites does not produce the migraine prevention effect.

Why your cosmetic Botox is not preventing migraines

This is a common point of confusion, and the explanation matters. A cosmetic glabellar treatment delivers 20-25 units to the corrugator and procerus muscles. The PREEMPT protocol delivers 10 units to those same muscles plus 145+ additional units across six other muscle groups. The cosmetic dose is not a "starter dose" of the migraine protocol — it is a different intervention entirely, in a different distribution, at a different total dose.

Some patients with cosmetic Botox notice modest headache improvement, particularly tension-type headache patients with significant frontalis or temporalis muscle contribution to their pain. That is real but it is not chronic migraine prevention. Recommending that a patient address chronic migraine with cosmetic-dose Botox is functionally the same as recommending it not be addressed at all.

Insurance coverage — what the reality actually looks like

Botox for chronic migraine is covered by most commercial insurance plans, Medicare, and Medicaid when properly documented. The path is consistent:

1. Documented diagnosis of chronic migraine by a qualified provider, with headache diary supporting the 15+ days/month threshold.
2. Failure of at least two oral migraine prevention medications from different drug classes (beta-blockers, anticonvulsants like topiramate, tricyclics, calcium channel blockers, or others). Each must have been trialed at adequate dose for adequate duration with documented inadequate response or intolerance.
3. Prior authorization submitted with the diagnosis, the diary, the prior failed medications, and the planned protocol.
4. Re-authorization typically required every 6-12 months with documented response (reduction in headache days).

Coverage when the documentation is in place is generally good. Self-pay cost without coverage is significant — typically $1,500 to $2,500 per session given the unit count, every twelve weeks. Some patients pay out of pocket; most should pursue coverage first.

The neurology question — when I refer out

This is where I want to be transparent about scope. Migraine prevention is a neurological intervention. The PREEMPT protocol is administered by neurologists, headache specialists, and a smaller number of advanced practice clinicians who have completed specific training in the protocol and who manage the broader migraine treatment plan that surrounds it.

For patients who present to my Columbus or Warner Robins clinic asking about Botox for chronic migraine, my approach is:

• If you have a neurologist or headache specialist managing your migraines and you want the Botox component delivered, that is a coordination conversation with your specialist. We can sometimes serve in that role; sometimes the better answer is to receive the Botox at the same practice that is managing the rest of your prevention plan.
• If you do not have a neurologist and you are presenting with a chronic migraine pattern, the better next step is a neurology referral first. Migraine prevention is more than the injection — it is a full prevention strategy that includes oral medications, lifestyle modification, trigger identification, and abortive optimization. A standalone injection without that surrounding structure underperforms.
• If you have already established with a neurologist, failed appropriate prevention trials, and are now in the position where the PREEMPT protocol is the indicated next step, we can deliver the protocol with coordination.

I will not deliver a partial PREEMPT protocol or a "we'll add some extra units to your cosmetic visit" approximation. That is not what the FDA approval supports, that is not what the evidence supports, and that is not what insurance will cover. I would rather refer you to the right setting than do a half-version of the right protocol.

How chronic migraine connects to the broader hormonal picture

This is the conversation that does not get had in most neurology offices and that I think matters. A meaningful percentage of women with chronic migraine experience a migraine pattern that is hormonally modulated — worsening in the perimenopause transition, exacerbated around menstruation, sometimes improved or destabilized during hormone therapy. The pattern is not universal but it is common enough that I screen for it in any female migraine patient in the 38-55 age range.

If the migraine pattern began or worsened in concert with perimenopausal symptoms, the prevention conversation should include an evaluation of the hormonal picture. Bioidentical progesterone in particular has documented effects on migraine frequency in some patients with hormonally-modulated patterns. I am not suggesting hormone optimization replaces standard migraine prevention — it does not — but I am suggesting that addressing both pictures often outperforms addressing either in isolation. That conversation can run parallel to the neurology pathway.

What I look for at the consultation

When a patient comes in asking about Botox for migraine, here is what I evaluate: the actual headache pattern (frequency, severity, character, associated features, triggers), the headache diary, prior abortive medications and response, prior preventive medications with doses and reasons for discontinuation, current neurology relationship if any, hormonal context if female and in the relevant age range, and insurance coverage feasibility.

I also set realistic expectations explicitly — response by treatment 2-3, not treatment 1, and a ceiling of about 50% reduction in 50% of properly selected patients. "No migraines at all" is not the typical outcome. The honest conversation about whether I am the right setting for the intervention happens at this visit, not after.

The concrete next step

If you have been told you have chronic migraine, you have failed at least two preventive medications, and you have been considering Botox as the next step — bring your headache diary, your medication history, your insurance card, and your neurology records (if you have a neurologist) to the consultation. We will work through whether the PREEMPT protocol fits your situation, whether the right delivery setting is our clinic or a neurology practice, and what the insurance pathway looks like.

If you are getting cosmetic Botox and you have been hoping it would help your migraines — it is most likely not helping in the way you are hoping for. The cosmetic dose at the cosmetic sites does not deliver the prevention protocol. The right next step is an honest evaluation of whether you actually have chronic migraine and, if you do, the right pathway to the right protocol.

If you are in the middle Georgia area — Columbus, Warner Robins, Phenix City, the Fort Benning community, or anywhere in the Chattahoochee Valley — and you have not yet established with a neurologist for migraine management, that is the right first call. I can help you decide whether the Botox protocol is the right next step after that evaluation; I cannot substitute for the broader migraine management plan that should surround it. Book a consultation through the book online portal or call either clinic, and bring the diary and the records when you come in.

TW

Travis Woodley

MSN, RN, CRNP — Platinum Biote Provider — Founder, Revitalize

Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.

Book a ConsultationCall (762) 261-3880

About Travis →More articles →Rebuild Institute →